The AKT inhibitor MK2206 suppresses airway inflammation and the pro-remodeling pathway in a TDI-induced asthma mouse model

被引:14
作者
Cui, Haiyan [1 ,2 ]
Cheng, Yuanxiong [2 ]
He, Yi [3 ]
Cheng, Weiying [2 ]
Zhao, Wenqu [1 ]
Zhao, Haijin [1 ]
Zhou, Fiona H. [4 ]
Wang, Liping [4 ]
Dong, Jianghui [4 ]
Cai, Shaoxi [1 ]
机构
[1] Southern Med Univ, Dept Resp & Crit Care Med, Chron Airway Dis Lab, Nanfang Hosp, 1838 North Guangzhou Ave, Guangzhou 510000, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[3] Southern Med Univ, Dept Immunol Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[4] Univ South Australia, UniSA Canc Res Inst, UniSA Clin & Hlth Sci, HB Bldg,Corner North Terrace,Morphett St, Adelaide, SA 5001, Australia
基金
中国国家自然科学基金; 英国医学研究理事会;
关键词
MK2206; TDI-induced asthma; airway inflammation; airway remodeling; AKT; OBSTRUCTIVE PULMONARY-DISEASE; BETA-CATENIN STABILIZATION; GROUP BOX 1; TOLUENE-DIISOCYANATE; OCCUPATIONAL ASTHMA; MECHANISMS; HYPERRESPONSIVENESS; ACTIVATION; RECEPTOR; CELLS;
D O I
10.3892/mmr.2020.11450
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cellular and molecular mechanisms via which MK2206, an AKT inhibitor, prevents the activation of AKT in toluene diisocyanate (TDI)-induced asthma remain unclear. Thus, the present study aimed to evaluate the potential effects of MK2206 on airway AKT activation, inflammation and remodeling in a TDI-induced mouse model of asthma. A total of 24 BALB/c mice were selected and randomly divided into untreated (AOO), asthma (TDI), MK2206 (TDI + MK2206), and dexamethasone (TDI + DEX) groups. Phosphorylated AKT (p-AKT), total AKT, airway remodeling indices, alpha-smooth muscle actin (alpha-SMA) and collagen I levels in pulmonary tissue were measured using western blotting. Airway inflammation factors, including interleukin (IL)-4, -5, -6, and -13 in bronchoalveolar lavage fluid (BALF) and IgE in serum, were determined using ELISA. Additionally, the airway hyperresponsiveness (AHR) and pulmonary pathology of all groups were evaluated. The results of the present study demonstrated that p-AKT levels in lung protein lysate were upregulated, and neutrophil, eosinophil and lymphocyte counts were increased in the lungs obtained from the asthma group compared with the AOO group. Both MK2206 and DEX treatment in TDI-induced mice resulted not only in the attenuation of AKT phosphorylation, but also reductions in neutrophil, eosinophil and lymphocyte counts in the lungs of mice in the asthma group. Consistently, increases in the levels of the inflammatory cytokines IL-4, -5, -6 and -13 analyzed in BALF, and serum IgE in the TDI group were demonstrated to be attenuated in the TDI + MK2206 and TDI + DEX groups. Furthermore, alpha-SMA and AHR were significantly attenuated in the TDI + MK2206 group compared with the TDI group. These results revealed that MK2206 not only inhibited AKT activation, but also served a role in downregulating airway inflammation and airway remodeling in chemical-induced asthma. Therefore, the findings of the present study may provide important insight into further combination therapy.
引用
收藏
页码:3723 / 3734
页数:12
相关论文
共 22 条
  • [1] Hesperidin Suppresses Ovalbumin-Induced Airway Inflammation in a Mouse Allergic Asthma Model
    Wei, Dajun
    Ci, Xinxin
    Chu, Xiao
    Wei, Miaomiao
    Hua, Shucheng
    Deng, Xuming
    INFLAMMATION, 2012, 35 (01) : 114 - 121
  • [2] Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model
    Kim, Dae Yong
    Park, Jung Won
    Jeoung, Dooil
    Ro, Jai Youl
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 612 (1-3) : 98 - 105
  • [3] Lipoxin A4 inhibits ovalbumin-induced airway inflammation and airway remodeling in a mouse model of asthma
    Liu, Yuanyuan
    Wei, Li
    He, Chao
    Chen, Ran
    Meng, Ling
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 349
  • [4] IL-27 alleviates airway remodeling in a mouse model of asthma via PI3K/Akt pathway
    Li, Xin
    Zhou, Ling
    Zhang, Zewen
    Liu, Yuanyuan
    Liu, Ju
    Zhang, Caiqing
    EXPERIMENTAL LUNG RESEARCH, 2020, 46 (3-4) : 98 - 108
  • [5] Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model
    Wei, Miaomiao
    Xie, Xianxing
    Chu, Xiao
    Yang, Xiaofeng
    Guan, Mingfeng
    Wang, Dacheng
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 382 - 389
  • [6] Protocatechuic acid suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model
    Wei, Miaomiao
    Chu, Xiao
    Guan, Mingfeng
    Yang, Xiaofeng
    Xie, Xianxing
    Liu, Fang
    Chen, Chengzhen
    Deng, Xuming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 15 (04) : 780 - 788
  • [7] Hesperidin Suppresses Ovalbumin-Induced Airway Inflammation in a Mouse Allergic Asthma Model
    Dajun Wei
    Xinxin Ci
    Xiao Chu
    Miaomiao Wei
    Shucheng Hua
    Xuming Deng
    Inflammation, 2012, 35 : 114 - 121
  • [8] A bacterial extract of OM-85 Broncho-Vaxom suppresses ovalbumin-induced airway inflammation and remodeling in a mouse chronic allergic asthma model
    Zhong, Hua
    Wei, Jiawei
    Yao, Yin
    Fu, Ran
    Li, Hang
    Fu, Qingling
    Wen, Weiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 1149 - 1157
  • [9] Vitex rotundifolia L. prevented airway eosinophilic inflammation and airway remodeling in an ovalbumin-induced asthma mouse model
    Bae, Hyunsu
    Kim, Youngeun
    Lee, Euijeong
    Park, Soojin
    Jung, Kyung-Hwa
    Gu, Min-Jung
    Hong, Seon-Pyo
    Kim, Jinju
    INTERNATIONAL IMMUNOLOGY, 2013, 25 (03) : 197 - 205
  • [10] ABHD2 deficiency aggravates ovalbumin-induced airway remodeling through the PI3K/Akt pathway in an animal model of chronic asthma
    Qiang, L.
    Li, X.
    Li, Q.
    Bo, H.
    Liu, Y.
    Lv, M.
    Chen, X.
    Ju, H.
    Sang, X.
    Li, Z.
    Jin, S.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2023, 26 (04): : 635 - 646